May 14 (Reuters) - Ultimovacs ASA ULTIMO.OL :
* Q1 OPERATING LOSS NOK 31.3 MILLION VERSUS LOSS NOK 15.0
MILLION
YEAR AGO
* Q1 TOTAL OPERATING EXPENSES NOK 31.3 MILLION VERSUS NOK
15.0
MILLION YEAR AGO
* DESPITE TEMPORARY HALT IN CLINICAL TRIALS AT SEVERAL
HOSPITALS
CAUSED BY COVID-19, FIRST SITE IN INITIUM TRIAL HAS RECENTLY
OPENED FOR PATIENT INCLUSION
Source text for Eikon: ID:nObicFrsWa
Further company coverage: ULTIMO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))